Mera Pharmaceuticals, Inc. (MRPI)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Mera Pharmaceuticals Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2011 | -0.0722M |
| July 31, 2011 | 0.0027M |
| April 30, 2011 | -0.0057M |
| January 31, 2011 | 0.001M |
| October 31, 2010 | 0.0051M |
| July 31, 2010 | -0.0024M |
| April 30, 2010 | 0.001M |
| January 31, 2010 | -0.0009M |
| October 31, 2009 | -0.0088M |
| July 31, 2009 | -0.0848M |
| April 30, 2009 | 0.0427M |
| January 31, 2009 | 0.0003M |
| October 31, 2008 | -0.0816M |
| July 31, 2008 | -0.0004M |
| April 30, 2008 | -0.0128M |
| January 31, 2008 | -0.0237M |
| October 31, 2007 | 0.0059M |
| July 31, 2007 | 0.0213M |
| April 30, 2007 | 0.0005M |
| January 31, 2007 | -0.0816M |
| October 31, 2006 | -0.0492M |
| July 31, 2006 | -0.0558M |
| April 30, 2006 | -0.0924M |
| January 31, 2006 | -0.0331M |
| October 31, 2005 | -0.0559M |
| Date | Value |
|---|---|
| July 31, 2005 | -0.1866M |
| April 30, 2005 | -0.1335M |
| January 31, 2005 | -0.1914M |
| October 31, 2004 | -0.0676M |
| July 31, 2004 | -0.2968M |
| April 30, 2004 | -0.5006M |
| January 31, 2004 | -0.3986M |
| October 31, 2003 | -0.0324M |
| July 31, 2003 | -0.1411M |
| April 30, 2003 | -0.2252M |
| January 31, 2003 | -0.7633M |
| October 31, 2002 | 1.096M |
| July 31, 2002 | -0.9228M |
| April 30, 2002 | -0.2997M |
| January 31, 2002 | -0.2515M |
| October 31, 2001 | -0.4168M |
| July 31, 2001 | -0.8242M |
| April 30, 2001 | -0.8128M |
| January 31, 2001 | -1.252M |
| October 31, 2000 | -0.938M |
| July 31, 2000 | -0.8042M |
| April 30, 2000 | -1.100M |
| January 31, 2000 | -0.7542M |
| October 31, 1999 | -0.9276M |
| July 31, 1999 | -0.9431M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |
| Sarepta Therapeutics, Inc. | 196.52M |
| Anixa Biosciences, Inc. | -1.77M |